SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-18-032350
Filing Date
2018-05-11
Accepted
2018-05-11 06:17:46
Documents
124
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A a18-11226_120fa.htm 20-F/A 42424
  Complete submission text file 0001104659-18-032350.txt   15505130

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT tig-20171231.xml EX-101.INS 5298960
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tig-20171231.xsd EX-101.SCH 172400
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tig-20171231_cal.xml EX-101.CAL 100769
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tig-20171231_def.xml EX-101.DEF 440093
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tig-20171231_lab.xml EX-101.LAB 1039189
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tig-20171231_pre.xml EX-101.PRE 787815
Mailing Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000
Business Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000 34918060946
TiGenix NV (Filer) CIK: 0001581987 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9
Type: 20-F/A | Act: 34 | File No.: 001-37965 | Film No.: 18824868
SIC: 2834 Pharmaceutical Preparations